FINNEY ELISHA W 4
Research Summary
AI-generated summary
ICU Medical Director Elisha Finney Receives 1,475 RSUs, Converts 1,254
What Happened Elisha W. Finney, a director of ICU Medical, converted/exercised 1,254 derivative securities (transaction code M) on 2026-05-13 and the filing also shows those 1,254 shares were disposed the same day. On the same date Finney was granted 1,475 Restricted Stock Units (RSUs) (transaction code A). All reported transactions list $0.00 as the purchase/exercise price; the RSUs have no exercise price and no cash was reported exchanged.
Key Details
- Transaction date: 2026-05-13 (filing accession 0001217439-26-000001; filing date 2026-05-13).
- Converted/exercised: 1,254 derivative units at $0.00 (acquired) and 1,254 shares disposed at $0.00 (derivative conversion + same-day disposition).
- Grant/award: 1,475 RSUs at $0.00 (no purchase/exercise price).
- Shares owned after the transaction: Not disclosed in the provided filing excerpt.
- Footnotes: F1 = these are Restricted Stock Units; F2 = no purchase or exercise price for the RSUs; F3 = RSUs vest on the anniversary of the grant or at the next annual stockholder meeting, whichever occurs first.
- Timeliness: Reported on the same date as the transactions (no late-filing indication in the provided data).
Context
- Transaction codes: M = exercise or conversion of derivative securities; A = grant/award of securities. The filing shows a conversion and same-day disposition of 1,254 derivative units and a separate grant of RSUs that will convert to shares only upon vesting.
- For retail investors: RSU grants are compensation and not cash purchases by the insider, so they don't directly signal a buy; the conversion+disposition is a neutral reporting event without a disclosed cash value in this filing.